Ubs Group Ag Landec Corp \Ca\ Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Ubs Group Ag holds 24,789 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,789

Previous 75,764 67.28%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	N/A	-50,975 Reduced 67.28%	24,789 $0
Q4 2023 Feb 09, 2024	SELL	N/A	-5,767 Reduced 7.07%	75,764 $0
Q3 2023 Nov 09, 2023	BUY	N/A	76,531 Added 1530.62%	81,531 $0
Q2 2023 Aug 11, 2023	SELL	N/A	-26,169 Reduced 83.96%	5,000 $0
Q1 2023 May 12, 2023	BUY	N/A	1,667 Added 5.65%	31,169 $0

Q4 2022 Feb 08, 2023	BUY	$0.0 - $9.95 $0 - $65,560	6,589 Added 28.76%	29,502 $0
Q3 2022 Nov 10, 2022	SELL	$8.57 - $11.57 $1,688 - $2,279	-197 Reduced 0.85%	22,913 $204,000
Q2 2022 Aug 10, 2022	SELL	$8.84 - $11.64 $57,557 - $75,788	-6,511 Reduced 21.98%	23,110 $231,000
Q1 2022 May 16, 2022	SELL	$10.07 - $11.93 $177,131 - $209,848	-17,590 Reduced 37.26%	29,621 $343,000
Q4 2021 Feb 14, 2022	BUY	$7.95 - $11.24 $95,169 - $134,554	11,971 Added 33.97%	47,211 $524,000
Q3 2021 Nov 15, 2021	BUY	$9.22 - $12.44 $8,980 - $12,116	974 Added 2.84%	35,240 $325,000
Q2 2021 Aug 13, 2021	SELL	$9.91 - $12.78 $104,946 - $135,340	-10,590 Reduced 23.61%	34,266 $386,000
Q1 2021 May 12, 2021	BUY	$10.44 - $12.22 $140,626 - $164,603	13,470 Added 42.92%	44,856 $475,000
Q4 2020 Feb 11, 2021	BUY	$9.3 - $11.77 $56,618 - $71,655	6,088 Added 24.07%	31,386 $340,000
Q3 2020 Nov 12, 2020	SELL	$7.59 - $10.8 $51,019 - $72,597	-6,722 Reduced 20.99%	25,298 $246,000
Q2 2020 Jul 31, 2020	BUY	$7.96 - $11.54 $2,849 - $4,131	358 Added 1.13%	32,020 $254,000
Q1 2020 May 01, 2020	SELL	$7.69 - $11.68 $94,686 - $143,815	-12,313 Reduced 28.0%	31,662 $275,000
Q4 2019 Feb 14, 2020	BUY	$9.09 - $11.89 $99,980 - $130,778	10,999 Added 33.35%	43,975 $497,000
Q3 2019 Nov 14, 2019	BUY	$9.66 - $12.36 $94,474 - $120,880	9,780 Added 42.16%	32,976 $359,000
Q2 2019 Aug 14, 2019	BUY	$9.32 - $12.98 $81,587 - $113,626	8,754 Added 60.61%	23,196 $218,000
Q1 2019 May 14, 2019	SELL	$10.35 - $13.06 $94,640 - $119,420	-9,144 Reduced 38.77%	14,442 $177,000
Q4 2018 Feb 14, 2019	SELL	$11.64 - $15.41 $20,579 - $27,244	-1,768 Reduced 6.97%	23,586 $280,000
Q3 2018 Nov 14, 2018	BUY	$12.65 - $15.15 $41,757 - $50,010	3,301 Added 14.97%	25,354 $365,000
Q2 2018 Aug 14, 2018	BUY	$13.05 - $15.45 $43,587 - $51,603	3,340 Added 17.85%	22,053 $329,000
Q1 2018 May 15, 2018	SELL	$12.0 - $14.45 $19,164 - $23,076	-1,597 Reduced 7.86%	18,713 $244,000
Q4 2017 Feb 14, 2018	SELL	$11.65 - $13.35 $12,267 - $14,057	-1,053 Reduced 4.93%	20,310 $256,000
Q3 2017 Nov 14, 2017	BUY	$11.95 - $13.35 $12,368 - $13,817	1,035 Added 5.09%	21,363 $277,000
Q2 2017 Aug 14, 2017	BUY	N/A	186 Added 0.92%	20,328 $302,000
Q1 2017 Nov 14, 2017	BUY	N/A	20,142	20,142 $242,000

Others Institutions Holding LNDC

# of Institutions

Shares Held

20.2M

Call Options Held

114K

Put Options Held

82.1K

View Full List

About LANDEC CORP \CA\

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

More about LNDC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account